Clinical trials
Humans clinical trials
Below are recruiting humans clinical trials, each written for real people, not researchers. We’re tracking 1,228 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07436195Recruiting
Epigenetics and cell-free DNA in gestational diabetes study
This study looks at how changes in DNA (called epigenetics) might affect gestational diabetes in pregnancy. It aims to understand these changes using cell-free DNA from the mother and father.
Ulm, Baden-WurttembergAges 18 years+ - NCT06424964Recruiting
HIV treatment study for injectable cabotegravir/rilpivirine in Belgium
This study looks at people in Belgium who have already received at least one dose of a long-acting injectable HIV medication called cabotegravir/rilpivirine. The goal is to learn more about how this treatment works in real-world settings.
BrusselsAges 18–99 - NCT06809699RecruitingPhase 1
Stem cell transplant using a partially matched family donor
This trial tests a stem cell transplant from a family donor whose tissue type is only partly matched, for adults with blood cancers who don't have a fully matched sibling or other closely matched donor. The goal is to make transplant possible for more patients.
Hangzhou, ChinaAges 18–60 - NCT06083649Recruiting
Dental education: AI vs. human counseling for gum disease
This trial compares two ways of teaching about dental care—AI-assisted education versus speaking with a counselor—to see which one helps people with gum disease better control plaque and improve treatment outcomes.
Kaohsiung CityAges 35–65 - NCT06281080Recruiting
New robotic tool for removing early bladder tumors
This trial tests a new robotic system to remove bladder tumors in one piece (en-bloc resection) for people with early-stage, non-muscle invasive bladder cancer. It may offer a more precise surgical option for eligible patients.
ShatinAges 18–75 - NCT07429617Recruiting
Darkness retreat study for healthy adults
This study explores the effects of spending time in complete darkness. You might join if you are generally healthy, not taking any mental health medication, and not currently in therapy.
Poznan, WielkopolskaAges 30–50 - NCT07433049Recruiting
Health supplement study for midlife women
This study tests whether a nutritional supplement can improve metabolic health in women aged 40-60 who are Chinese, Malay, or Indian and have a BMI between 23 and 35. The goal is to see if the supplement helps with weight, blood sugar, and other health markers.
SingaporeAges 40–60 - NCT07434895RecruitingEarly Phase 1
Can CBD Change How You Use Cannabis?
This study looks at how taking CBD (a cannabis compound that doesn't get you high) affects your cannabis use. It is for healthy adults who use cannabis for recreational reasons, not for medical treatment.
Lexington, KentuckyAges 18–55 - NCT07429071Recruiting
Vaginal gel for HPV and early cervical changes
This study tests whether a vaginal gel can help early cervical cell changes (CIN1 or CIN2) go away on their own and clear the HPV virus. If you are being monitored without treatment, this gel might increase your chances of recovery.
HorsensAges 30–50 - NCT04048993Recruiting
Uses exercise testing to study health in a biobank
This study builds a biobank (a library of health samples and data) using people who can do difficult exercise. It aims to understand how the body works by collecting physical measurements, which may help future research and treatments.
CopenhagenAges 18 years+ - NCT06123884RecruitingPhase 2/Phase 3
BAT1308 plus chemotherapy for PD-L1-positive cervical cancer
This clinical trial tests a new combination therapy (BAT1308 plus chemotherapy, with or without Avastin) for women with advanced cervical cancer that is PD-L1-positive and has not been previously treated with systemic therapy. The goal is to see if this combination can shrink tumors or slow disease progression.
Wuhan, HubeiAges 18–70 - NCT06275230Recruiting
Growing lung stem cells from COPD patients
This trial aims to grow lung stem cells and create mini-lungs (organoids) from the tissue of people with COPD. It may help researchers understand the disease better and develop new treatments.
Beijing, Beijing MunicipalityAges 18–55 - NCT07423299RecruitingPhase 1
First human safety study of MT-251 in healthy volunteers
This is the first human study of a new medication called MT-251. It is a safety study, so healthy volunteers are given either a single dose or multiple doses of the drug to see how the body handles it and if there are any side effects.
San Diego, CaliforniaAges 19–55 - NCT07416526RecruitingPhase 3
Testing NXT007 for hemophilia A without inhibitors
This study tests a new medicine called NXT007 for people with hemophilia A. It compares NXT007 to standard factor VIII treatment to see if it works better at preventing bleeding episodes.
Aurora, ColoradoAges 12 years+ - NCT07425080Recruiting
Light treatment for IVF eggs to improve development
This trial tests whether giving brief light exposure to eggs during IVF can help more become healthy embryos. You may be eligible if you are using your own eggs for IVF and plan to transfer a genetically normal embryo soon.
New York, New YorkAges 18–48 - NCT07416786Recruiting
Testing NAD+ levels in healthy young and older adults
This study measures NAD+ (a molecule linked to aging) in healthy adults aged 18-35 or 70+. It will help researchers understand how NAD+ changes with age and if supplements like NR affect it.
Philadelphia, PennsylvaniaAges 18–110 - NCT07423923Enrolling by invitationEarly Phase 1
Memory and navigation study in healthy adults
This study uses brain scans (fMRI or iEEG) to understand how healthy people remember locations and navigate spaces. You may be eligible if you are a healthy adult aged 18–40 and meet the screening criteria.
Tucson, ArizonaAges 18–40 - NCT07419048Recruiting
AI vs. human for hydration check
This study uses an ultrasound method to check your hydration status, comparing artificial intelligence (computer analysis) with a human expert. It aims to see if AI can accurately assess how hydrated you are.
BaselAges 18 years+ - NCT07418385Recruiting
Voluntary HIV testing for adults in France
This study offers free, voluntary HIV testing to anyone in France who is 18 or older. It aims to make HIV screening easy and accessible, regardless of your sexual history or past testing.
ReimsAges 18 years+ - NCT07419178Recruiting
New scan test for scarring in blood cancers
This study tests a new way to detect scar tissue in the bone marrow using a special scan and blood test. It might help doctors see how your disease is changing without needing a bone marrow biopsy.
Parma, ItalyAges 18 years+ - NCT06337942Recruiting
Bladder or kidney-bladder transplant from a deceased donor
This trial offers a first-in-human transplant of a bladder or a kidney combined with a bladder from a deceased donor. It is for people with severe bladder problems or bladder cancer who already need a new bladder or are on immune-suppressing medicines for a prior organ transplant.
Los Angeles, CaliforniaAges 18–70 - NCT07414836RecruitingPhase 1
First test of new drug BG-C0979 for advanced solid tumors
This study tests a new drug called BG-C0979 for advanced solid tumors that have not responded to standard treatments. It may be given alone or with other therapies to see if it can shrink tumors or slow cancer growth.
Boston, MassachusettsAges 18 years+ - NCT07412288RecruitingPhase 1
Safety study of KT-579 in healthy volunteers
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
Lincoln, NebraskaAges 18–55 - NCT07414368Enrolling by invitation
StimLabs umbilical cord material for wound healing
This study looks at how a wound treatment made from donated human umbilical cord tissue works for both new and long-lasting wounds. The treatment is a dehydrated powder that is applied directly to the wound.
Bridgeport, ConnecticutAges 18 years+
Hear when a new Humans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for humans?
- Yes. Clin2 currently lists 1,228 recruiting humans studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a humans trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a humans trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.